Gufic Biosciences Limited (NSE:GUFICBIO)
India · Delayed Price · Currency is INR 384.65
-12.45 (-3.14%)
Aug 1, 2025, 3:29 PM IST
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 38.53 billion as of August 1, 2025. Its market cap has increased by 9.47% in one year.
Market Cap
38.53B
Enterprise Value
41.60B
Revenue
8.20B
Ranking
n/a
PE Ratio
55.32
Stock Price
384.65
Market Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 38.53B, an increase of 10,687.67%. That is a compound annual growth rate of 21.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 38.53B | -15.74% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | 9.10B | 91.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,104.06B |
| Divi's Laboratories | 1,772.40B |
| Cipla | 1,259.61B |
| Apollo Hospitals Enterprise | 1,072.06B |
| Mankind Pharma | 1,054.40B |
| Zydus Lifesciences | 1,001.35B |
| Aurobindo Pharma | 672.63B |
| Fortis Healthcare | 642.17B |